Lipopepidomimetics as Inhibitor of Protein-protein Interactions: The Case of Med25

A lipopeptidomimetics is conceptually interesting mimetics of peptides for modulation of protein-protein interactions (PPIs). Lipopeptidomimetics are the mimic of lipopeptides and/or derivatives of peptidomimetics with a fatty acid residue. A lipopeptide is a class of molecule with a structure of a peptide connected to a fatty acid. It’s abundant in microbes and its amphiphilic nature...

Ternary Complex Design for Modulating Protein-Protein Interactions

Protein-protein interaction (PPIs)-targeted drug discovery program can accommodate multiple strategies through direct interference, stabilization and indirect modulations, Ternary complex design is an emerging approach of mimicking biological process and recognition machinery by a monovalent “molecular glue” or a bivalent small molecule.1) Since the appearance of PPI inhibitors in 20042) and its evolution to clinical trials...

Molecular chameleons: Oral Absorption Analysis in Middle-Sized Molecules

Oral drugs diminish the stress of disease treatments. Oral bioavailability is governed by multiple parameters: membrane permeability, action of transporters, metabolism (notably the first pass effect) and so on. Cell permeability is a requisite physicochemical parameter for oral absorption. Recent advance towards the discovery of a molecular chameleon1) and innovation in analytical methods is providing...

TACnology:

TACnology is an emerging term in pharmaceutical science.1) Modulation of the posttranslational modification (PTM) machinery in nature enables us to control the natural biological process toward the desired direction. PROTAC (PROteolysis TArgeting Chimera) is the most popular TACnology but proteolysis is not the only target for drug design. Chimera molecule-mediated targeting of a particular biological...